BREAST CANCER STAGE III
Clinical trials for BREAST CANCER STAGE III explained in plain language.
Never miss a new study
Get alerted when new BREAST CANCER STAGE III trials appear
Sign up with your email to follow new studies for BREAST CANCER STAGE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a chemo pill mop up hidden breast cancer cells?
Disease control Recruiting nowThis phase 2 trial tests whether the chemotherapy pill capecitabine can eliminate tiny amounts of cancer DNA still present in the blood after standard treatment for early-stage ER+/HER2- breast cancer. About 15 patients whose blood tests show residual cancer DNA will take capecit…
Matched conditions: BREAST CANCER STAGE III
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Timing is everything: new trial tests best duration of hormone therapy before breast cancer surgery
Disease control Recruiting nowThis study looks at how long hormone-blocking therapy given before surgery (neoadjuvant endocrine therapy) affects breast cancer in people with early-stage disease. About 90 participants will receive therapy for different lengths of time, from weeks up to a year. Researchers want…
Matched conditions: BREAST CANCER STAGE III
Phase: PHASE2 • Sponsor: George Washington University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Triple threat: radiation and immunotherapy before chemotherapy may boost breast cancer response
Disease control Recruiting nowThis phase 2 trial is testing whether giving a short course of radiation (SBRT) and two injections of the immunotherapy drug pembrolizumab (Keytruda) before standard chemotherapy can improve outcomes for people with stage 2 or 3 breast cancer. The study aims to see if this combin…
Matched conditions: BREAST CANCER STAGE III
Phase: PHASE2 • Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Cherry juice tested as shield against chemo nerve pain
Prevention Recruiting nowThis phase 2 trial tests whether drinking tart cherry juice can prevent nerve damage (neuropathy) caused by the chemotherapy drug paclitaxel in breast and ovarian cancer patients. About 86 participants will be randomly assigned to receive either a high or low dose of the juice du…
Matched conditions: BREAST CANCER STAGE III
Phase: PHASE2 • Sponsor: University of California, Davis • Aim: Prevention
Last updated Jun 27, 2026 09:10 UTC
-
Could eating only during daylight hours improve cancer treatment?
Symptom relief Recruiting nowThis study tests whether eating only within an 8-hour window (time-restricted eating) can improve how well cancer treatments work and reduce side effects. It involves 100 Alaska Native and American Indian patients with breast or rectal cancer. Participants will follow the eating …
Matched conditions: BREAST CANCER STAGE III
Phase: NA • Sponsor: Fred Hutchinson Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Can a Culturally-Tailored therapy reduce anxiety in advanced cancer patients?
Symptom relief Recruiting nowThis study tests whether a therapy called Meaning-Centered Psychotherapy for Latinos (MCP-L) can help reduce anxiety and depression in 300 Latino patients with advanced cancer. Participants receive either MCP-L or standard cognitive behavioral therapy over about 3 months. The goa…
Matched conditions: BREAST CANCER STAGE III
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Exercise and drug combo may fight chemo brain fog
Symptom relief Recruiting nowThis study tests whether combining the drug memantine with a structured exercise program can improve memory and thinking problems (often called 'chemo brain') in women with early-stage breast cancer undergoing chemotherapy. Ninety participants will be split into three groups: mem…
Matched conditions: BREAST CANCER STAGE III
Phase: PHASE2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Could a rice bran supplement ease chemo side effects?
Symptom relief Recruiting nowThis study tests whether a dietary supplement called Biobran, made from rice bran, can help women with stage I-III breast cancer who are receiving chemotherapy. The goal is to see if it reduces side effects and improves quality of life. About 96 participants will take Biobran dai…
Matched conditions: BREAST CANCER STAGE III
Phase: NA • Sponsor: China Medical University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Can a Home-Based virtual program help cancer survivors regain their lives?
Symptom relief Recruiting nowThis study tests an 8-week virtual rehab program (CaRE@Home) for adults who finished cancer treatment for breast, colorectal, head and neck cancers, or lymphoma within the last two years. The goal is to see if the program reduces disability and improves physical function, anxiety…
Matched conditions: BREAST CANCER STAGE III
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
Can Real-Time interpreting cut errors in cancer care?
Knowledge-focused Recruiting nowThis study compares three types of remote medical interpreting for Spanish- and Mandarin-speaking breast cancer patients with limited English proficiency. Researchers will measure how many interpretation errors occur during doctor visits. The goal is to find which method works be…
Matched conditions: BREAST CANCER STAGE III
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Small study aims to predict which breast cancer patients benefit from immunotherapy
Knowledge-focused Recruiting nowThis pilot study is looking at how the immune system responds in people with early-stage triple negative breast cancer who receive standard chemotherapy plus the immunotherapy drug pembrolizumab before surgery. The goal is to see if certain immune markers in the blood or tumor ti…
Matched conditions: BREAST CANCER STAGE III
Sponsor: Emory University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
New web tool aims to ease tough surgery decisions for young breast cancer patients
Knowledge-focused Recruiting nowThis study looks at whether a web-based tool called CONSYDER can help young women (ages 18-44) newly diagnosed with early-stage breast cancer make more informed decisions about their surgery. Participants will use the tool and complete surveys before and after their surgical cons…
Matched conditions: BREAST CANCER STAGE III
Phase: NA • Sponsor: Weill Medical College of Cornell University • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:24 UTC